Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.
暂无分享,去创建一个
U. Liebchen | Alexander Kratzer | Uwe Liebchen | Michael Schleibinger | Martin G Kees | Frieder Kees | M. Kees | F. Kees | A. Kratzer | M. Schleibinger
[1] Martin Brunner,et al. Impaired target site penetration of &bgr; -lactams may account for therapeutic failure in patients with septic shock , 2001, Critical care medicine.
[2] Masao Kobayashi,et al. High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[4] J. Rello,et al. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. , 2010, The Journal of antimicrobial chemotherapy.
[5] Jingwei Shao,et al. Compilation of 222 drugs' plasma protein binding data and guidance for study designs. , 2012, Drug discovery today.
[6] W. Vetter,et al. Isolation of 6,9,12,15-Hexadecatetraenoic Fatty Acid (16:4n-1) Methyl Ester from Transesterified Fish Oil by HSCCC , 2011, Chromatographia.
[7] N. Williams,et al. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. , 2013, Journal of pharmaceutical and biomedical analysis.
[8] K. Korzekwa,et al. Impact of pH on plasma protein binding in equilibrium dialysis. , 2008, Molecular pharmaceutics.
[9] Stephan Schmidt,et al. Effect of Protein Binding on the Pharmacological Activity of Highly Bound Antibiotics , 2008, Antimicrobial Agents and Chemotherapy.
[10] D. Musson,et al. Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[11] T. Bjornsson,et al. The artifactual nature of heparin‐induced drug protein‐binding alterations , 1981, Clinical pharmacology and therapeutics.
[12] J. Roberts,et al. A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] J. Roberts,et al. The Clinical Relevance of Plasma Protein Binding Changes , 2012, Clinical Pharmacokinetics.
[14] G. McMillin,et al. Effect of Ultrafiltrate Volume on Determination of Free Phenytoin Concentration , 2005, Therapeutic drug monitoring.
[15] J. Roberts,et al. Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] V. Samanidou,et al. Chromatographic analysis of penicillins in pharmaceutical formulations and biological fluids. , 2006, Journal of separation science.
[17] C. Michelet,et al. Simultaneous Determination of 12 β-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring , 2011, Antimicrobial Agents and Chemotherapy.
[18] O. Brørs,et al. pH lability in serum during equilibrium dialysis. , 1985, British journal of clinical pharmacology.
[19] C. Jarry,et al. Determination of third-generation cephalosporins by high-performance liquid chromatography in connection with pharmacokinetic studies. , 1998, Journal of chromatography. A.
[20] Rachel F. Eyler,et al. Pharmacokinetics of Ertapenem in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis or Hemodiafiltration , 2013, Antimicrobial Agents and Chemotherapy.
[21] A. Lorenzo,et al. Effects of pressure on the plasma binding of digoxin and ouabain in an ultrafiltration apparatus. , 1973, Biochemical pharmacology.
[22] A. Fura,et al. Shift in pH of biological fluids during storage and processing: effect on bioanalysis. , 2003, Journal of pharmaceutical and biomedical analysis.
[23] N. D. Kim,et al. Factors influencing the protein binding of vancomycin , 1991, Biopharmaceutics & drug disposition.
[24] R. White,et al. Comparative Stability of Cephalothin and Cefazolin in Buffer or Human Serum , 1977, Antimicrobial Agents and Chemotherapy.
[25] D. Breilh,et al. Diffusion of ertapenem into bone and synovial tissues. , 2007, The Journal of antimicrobial chemotherapy.
[26] Carsten Gnewuch,et al. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. , 2010, International journal of antimicrobial agents.
[27] H. Ushikoshi,et al. Simultaneous determination of eight β-lactam antibiotics in human serum by liquid chromatography-tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[28] Yi Wang,et al. Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants , 2013, European Journal of Clinical Pharmacology.
[29] S. Wicha,et al. Unbound fraction of vancomycin in intensive care unit patients , 2014, Journal of clinical pharmacology.
[30] A. Marzo,et al. Chromatography as an analytical tool for selected antibiotic classes: a reappraisal addressed to pharmacokinetic applications. , 1998, Journal of chromatography. A.
[31] S. Bauer,et al. Therapeutic Drug Monitoring of Piperacillin-Tazobactam Using Spent Dialysate Effluent in Patients Receiving Continuous Venovenous Hemodialysis , 2010, Antimicrobial Agents and Chemotherapy.
[32] A. Pesce,et al. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. , 1982, Clinical chemistry.
[33] K. Brown,et al. Ultrafiltration in serum protein binding determinations. , 1981, Journal of pharmaceutical sciences.